LA JOLLA PHARMACEUTICAL CO - COM PAR $.0001 2 (LJPC)

CUSIP: 503459604

Q4 2017 13F Holders as of 31 Dec 2017

Type / Class
Equity / COM PAR $.0001 2
Total 13F shares
21,671,783
Share change
+1,347,679
Total reported value
$697,451,459
Put/Call ratio
175%
Price per share
$32.18
Number of holders
92
Value change
+$39,843,841
Number of buys
50
Number of sells
44

Quarterly Holders Quick Answers

What is CUSIP 503459604?
CUSIP 503459604 identifies LJPC - LA JOLLA PHARMACEUTICAL CO - COM PAR $.0001 2 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of LA JOLLA PHARMACEUTICAL CO - COM PAR $.0001 2 (LJPC) as of Q4 2017

As of 31 Dec 2017, LA JOLLA PHARMACEUTICAL CO - COM PAR $.0001 2 (LJPC) was held by 92 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 21,671,783 shares. The largest 10 holders included PERCEPTIVE ADVISORS LLC, FMR LLC, JENNISON ASSOCIATES LLC, Consonance Capital Management LP, BlackRock Inc., RTW INVESTMENTS, LP, Broadfin Capital, LLC, PICTET ASSET MANAGEMENT LTD, STATE STREET CORP, and Sectoral Asset Management Inc. This page lists 92 institutional shareholders reporting positions in this security for the Q4 2017 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.